What is oligozoospermia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Oligozoospermia?

Oligozoospermia is defined as low sperm concentration in the semen 1.

Clinical Definition and Diagnostic Thresholds

According to the most recent AUA/ASRM guidelines (2024), oligozoospermia represents a sperm concentration below the World Health Organization reference limits. The WHO defines the lower reference limit (fifth centile) for normal sperm concentration as 16 million sperm/mL (95% CI: 15-18 million/mL) 1. Any concentration below this threshold constitutes oligozoospermia.

Severity Classification

The severity of oligozoospermia has clinical implications:

  • Severe oligozoospermia: Sperm concentration <5 million/mL

    • This threshold is particularly important because genetic testing (karyotype and Y-chromosome microdeletion screening) is recommended when sperm concentration falls below 5 million/mL, especially when accompanied by elevated FSH, testicular atrophy, or diagnosed impaired sperm production 1
  • Moderate oligozoospermia: Sperm concentration 5-16 million/mL

  • Cryptozoospermia: Extremely low counts <1,000 sperm/mL (10³ sperm/mL), representing the most severe form where sperm are only occasionally found after extensive searching 2

Clinical Context and Associated Findings

Oligozoospermia rarely occurs in isolation. It is frequently accompanied by other sperm abnormalities including reduced motility (asthenozoospermia) and abnormal morphology (teratozoospermia), reflecting both quantitative and qualitative defects in spermatogenesis 3, 4. These combined defects suggest underlying problems with the entire spermatogenic process rather than isolated concentration issues.

Diagnostic Considerations

At least two semen analyses obtained one month apart are essential for diagnosis 1, as semen parameters are highly variable biological measures that can fluctuate substantially between tests. This is particularly critical if the first analysis shows abnormal parameters.

Genetic Implications

The genetic risk increases with severity:

  • Y-chromosome microdeletions occur in approximately 5% of males with sperm concentrations 0-1 million/mL
  • The frequency drops to only 0.8% in males with concentrations >1-5 million/mL 1

**Men with severe oligozoospermia (<5 million/mL) should undergo karyotype testing and Y-chromosome microdeletion screening**, particularly when accompanied by elevated FSH (>7.6 IU/L), testicular atrophy, or evidence of impaired sperm production 1.

Etiology

Oligozoospermia can result from:

  • Obstructive causes: Partial obstruction of the seminal pathway, with varicocele being a principal cause 5
  • Non-obstructive causes: Primary testicular dysfunction or hypothalamic-pituitary-gonadal axis dysfunction 6
  • Idiopathic: Most cases remain unexplained despite thorough evaluation 3

The distinction between obstructive and non-obstructive oligozoospermia has important treatment implications, with quantitative testicular biopsy analysis being the definitive diagnostic method 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.